Banks - Regional
Compare Stocks
4 / 10Stock Comparison
CARE vs NFBK vs NBTB vs CSGP
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Real Estate - Services
CARE vs NFBK vs NBTB vs CSGP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Real Estate - Services |
| Market Cap | $580M | $588M | $2.35B | $14.83B |
| Revenue (TTM) | $255M | $251M | $867M | $3.41B |
| Net Income (TTM) | $31M | $39M | $169M | $25M |
| Gross Margin | 61.7% | 49.1% | 72.1% | 77.4% |
| Operating Margin | 15.7% | 16.1% | 25.3% | -0.8% |
| Forward P/E | 4.8x | 10.4x | 10.8x | 25.8x |
| Total Debt | $179M | $760M | $327M | $1.14B |
| Cash & Equiv. | $105M | $168M | $185M | $1.73B |
CARE vs NFBK vs NBTB vs CSGP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Carter Bankshares, … (CARE) | 100 | 371.0 | +271.0% |
| Northfield Bancorp,… (NFBK) | 100 | 128.7 | +28.7% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
| CoStar Group, Inc. (CSGP) | 100 | 53.3 | -46.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CARE vs NFBK vs NBTB vs CSGP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CARE carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 112.9% 10Y total return vs NBTB's 102.2%
- Lower P/E (4.8x vs 25.8x)
- Beta 0.56 vs NFBK's 1.00, lower leverage
- +69.0% vs CSGP's -53.6%
NFBK is the clearest fit if your priority is income & stability.
- Dividend streak 10 yrs, beta 1.00, yield 3.7%
- 3.7% yield, 10-year raise streak, vs NBTB's 3.2%, (2 stocks pay no dividend)
NBTB is the #2 pick in this set and the best alternative if bank quality is your priority.
- NIM 3.1% vs NFBK's 2.0%
- 19.5% margin vs CSGP's 0.7%
- 1.1% ROA vs CSGP's 0.2%, ROIC 7.9% vs -0.9%
CSGP is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 18.7%, EPS growth -95.1%, 3Y rev CAGR 14.2%
- Lower volatility, beta 0.80, Low D/E 13.7%, current ratio 2.84x
- Beta 0.80, current ratio 2.84x
- 18.7% FFO/revenue growth vs CARE's 6.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% FFO/revenue growth vs CARE's 6.2% | |
| Value | Lower P/E (4.8x vs 25.8x) | |
| Quality / Margins | 19.5% margin vs CSGP's 0.7% | |
| Stability / Safety | Beta 0.56 vs NFBK's 1.00, lower leverage | |
| Dividends | 3.7% yield, 10-year raise streak, vs NBTB's 3.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +69.0% vs CSGP's -53.6% | |
| Efficiency (ROA) | 1.1% ROA vs CSGP's 0.2%, ROIC 7.9% vs -0.9% |
CARE vs NFBK vs NBTB vs CSGP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CARE vs NFBK vs NBTB vs CSGP — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 2 of 6 categories
CARE leads 1 • NFBK leads 0 • CSGP leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CSGP is the larger business by revenue, generating $3.4B annually — 13.6x NFBK's $251M. NBTB is the more profitable business, keeping 19.5% of every revenue dollar as net income compared to CSGP's 0.7%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $255M | $251M | $867M | $3.4B |
| EBITDAEarnings before interest/tax | $46M | $61M | $241M | $278M |
| Net IncomeAfter-tax profit | $31M | $39M | $169M | $25M |
| Free Cash FlowCash after capex | $30M | $42M | $225M | $241M |
| Gross MarginGross profit ÷ Revenue | +61.7% | +49.1% | +72.1% | +77.4% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +16.1% | +25.3% | -0.8% |
| Net MarginNet income ÷ Revenue | +12.3% | +11.9% | +19.5% | +0.7% |
| FCF MarginFCF ÷ Revenue | +12.5% | +11.9% | +25.2% | +7.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | +22.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +8.3% | +68.8% | +39.5% | +127.7% |
Valuation Metrics
NBTB leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, NBTB trades at a 99% valuation discount to CSGP's 2107.2x P/E. On an enterprise value basis, NBTB's 10.4x EV/EBITDA is more attractive than CSGP's 83.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $580M | $588M | $2.4B | $14.8B |
| Enterprise ValueMkt cap + debt − cash | $654M | $1.2B | $2.5B | $14.2B |
| Trailing P/EPrice ÷ TTM EPS | 18.71x | 19.54x | 13.53x | 2107.23x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.77x | 10.42x | 10.80x | 25.84x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.92x | — |
| EV / EBITDAEnterprise value multiple | 16.34x | 24.19x | 10.35x | 83.74x |
| Price / SalesMarket cap ÷ Revenue | 2.28x | 2.34x | 2.71x | 4.57x |
| Price / BookPrice ÷ Book value/share | 1.40x | 0.83x | 1.21x | 1.77x |
| Price / FCFMarket cap ÷ FCF | 18.25x | 19.64x | 10.75x | 361.59x |
Profitability & Efficiency
Evenly matched — NBTB and CSGP each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
NBTB delivers a 9.5% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $0 for CSGP. CSGP carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to NFBK's 1.08x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs CSGP's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.6% | +5.5% | +9.5% | +0.3% |
| ROA (TTM)Return on assets | +0.7% | +0.7% | +1.1% | +0.2% |
| ROICReturn on invested capital | +5.7% | +2.0% | +7.9% | -0.9% |
| ROCEReturn on capital employed | +1.5% | +2.5% | +2.4% | -0.8% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.43x | 1.08x | 0.17x | 0.14x |
| Net DebtTotal debt minus cash | $73M | $592M | $142M | -$589M |
| Cash & Equiv.Liquid assets | $105M | $168M | $185M | $1.7B |
| Total DebtShort + long-term debt | $179M | $760M | $327M | $1.1B |
| Interest CoverageEBIT ÷ Interest expense | 0.39x | 0.46x | 1.05x | 1.58x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,721 today (with dividends reinvested), compared to $4,112 for CSGP. Over the past 12 months, CARE leads with a +69.0% total return vs CSGP's -53.6%. The 3-year compound annual growth rate (CAGR) favors CARE at 24.9% vs CSGP's -22.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +34.8% | +26.5% | +9.3% | -46.7% |
| 1-Year ReturnPast 12 months | +69.0% | +31.5% | +9.0% | -53.6% |
| 3-Year ReturnCumulative with dividends | +94.7% | +65.7% | +54.1% | -52.9% |
| 5-Year ReturnCumulative with dividends | +87.2% | +0.2% | +29.9% | -58.9% |
| 10-Year ReturnCumulative with dividends | +112.9% | +20.6% | +102.2% | +77.5% |
| CAGR (3Y)Annualised 3-year return | +24.9% | +18.3% | +15.5% | -22.2% |
Risk & Volatility
Evenly matched — CARE and NFBK each lead in 1 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than NFBK's 1.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NFBK currently trades 99.0% from its 52-week high vs CSGP's 35.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.56x | 1.00x | 0.89x | 0.80x |
| 52-Week HighHighest price in past year | $26.58 | $14.21 | $46.92 | $97.43 |
| 52-Week LowLowest price in past year | $15.37 | $9.90 | $39.20 | $33.31 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +99.0% | +96.1% | +35.9% |
| RSI (14)Momentum oscillator 0–100 | 75.4 | 57.0 | 57.3 | 30.4 |
| Avg Volume (50D)Average daily shares traded | 276K | 258K | 236K | 5.9M |
Analyst Outlook
Evenly matched — NFBK and NBTB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CARE as "Buy", NFBK as "Hold", NBTB as "Hold", CSGP as "Buy". Consensus price targets imply 77.0% upside for CSGP (target: $62) vs 2.1% for NBTB (target: $46). For income investors, NFBK offers the higher dividend yield at 3.73% vs NBTB's 3.17%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $27.00 | $14.50 | $46.00 | $61.91 |
| # AnalystsCovering analysts | 4 | 9 | 10 | 25 |
| Dividend YieldAnnual dividend ÷ price | — | +3.7% | +3.2% | — |
| Dividend StreakConsecutive years of raises | 0 | 10 | 12 | — |
| Dividend / ShareAnnual DPS | — | $0.52 | $1.43 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | +3.2% | +0.4% | +3.9% |
NBTB leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). CARE leads in 1 (Total Returns). 3 tied.
CARE vs NFBK vs NBTB vs CSGP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CARE or NFBK or NBTB or CSGP a better buy right now?
For growth investors, CoStar Group, Inc.
(CSGP) is the stronger pick with 18. 7% revenue growth year-over-year, versus 6. 2% for Carter Bankshares, Inc. (CARE). NBT Bancorp Inc. (NBTB) offers the better valuation at 13. 5x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CARE or NFBK or NBTB or CSGP?
On trailing P/E, NBT Bancorp Inc.
(NBTB) is the cheapest at 13. 5x versus CoStar Group, Inc. at 2107. 2x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CARE or NFBK or NBTB or CSGP?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +87. 2%, compared to -58. 9% for CoStar Group, Inc. (CSGP). Over 10 years, the gap is even starker: CARE returned +112. 9% versus NFBK's +20. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CARE or NFBK or NBTB or CSGP?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus Northfield Bancorp, Inc. 's 1. 00β — meaning NFBK is approximately 77% more volatile than CARE relative to the S&P 500. On balance sheet safety, CoStar Group, Inc. (CSGP) carries a lower debt/equity ratio of 14% versus 108% for Northfield Bancorp, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CARE or NFBK or NBTB or CSGP?
By revenue growth (latest reported year), CoStar Group, Inc.
(CSGP) is pulling ahead at 18. 7% versus 6. 2% for Carter Bankshares, Inc. (CARE). On earnings-per-share growth, the picture is similar: Carter Bankshares, Inc. grew EPS 32. 1% year-over-year, compared to -95. 1% for CoStar Group, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CARE or NFBK or NBTB or CSGP?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus 0. 2% for CoStar Group, Inc. — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus -2. 2% for CSGP. At the gross margin level — before operating expenses — CSGP leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CARE or NFBK or NBTB or CSGP more undervalued right now?
On forward earnings alone, Carter Bankshares, Inc.
(CARE) trades at 4. 8x forward P/E versus 25. 8x for CoStar Group, Inc. — 21. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CSGP: 77. 0% to $61. 91.
08Which pays a better dividend — CARE or NFBK or NBTB or CSGP?
In this comparison, NFBK (3.
7% yield), NBTB (3. 2% yield) pay a dividend. CARE, CSGP do not pay a meaningful dividend and should not be held primarily for income.
09Is CARE or NFBK or NBTB or CSGP better for a retirement portfolio?
For long-horizon retirement investors, NBT Bancorp Inc.
(NBTB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), 3. 2% yield, +102. 2% 10Y return). Both have compounded well over 10 years (NBTB: +102. 2%, CSGP: +77. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CARE and NFBK and NBTB and CSGP?
These companies operate in different sectors (CARE (Financial Services) and NFBK (Financial Services) and NBTB (Financial Services) and CSGP (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CARE is a small-cap quality compounder stock; NFBK is a small-cap income-oriented stock; NBTB is a small-cap deep-value stock; CSGP is a mid-cap high-growth stock. NFBK, NBTB pay a dividend while CARE, CSGP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.